Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-Guided BTA vs Liraglutide for Obesity
NCT05268627Unknown
- Sponsor
- Mansoura University
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in obesity (2 arms), sponsored by Mansoura University. Primary endpoints: Weight Loss at 1 year, Body Mass Index at 1 year and 2 more. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05268627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05268627.